ESR1 and breast cancer: Finally, miR105 was shown to induce migration via the downregulation of ZO-1 in BC cells [81], and miR-222 and miR221 directly target ERα transcripts, conferring BC cells with a proliferative advantage and migratory activity, thus promoting the transition from ER+ to ER− tumors [82].